You are here

Article Text

Article menu
Download PDFPDF
Review
Empowering children and young people who have asthma
  1. Ian P Sinha1,2,
  2. Lynsey Brown1,
  3. Olivia Fulton1,
  4. Lucy Gait1,
  5. Christopher Grime1,
  6. Claire Hepworth1,
  7. Andrew Lilley1,
  8. Morgan Murray1,
  9. Justus Simba1,3
  1. 1 Alder Hey Children's NHS Foundation Trust, Liverpool, UK
  2. 2 Division of Child Health, University of Liverpool, Liverpool, UK
  3. 3 Child Health and Paediatrics, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
  1. Correspondence to Dr Ian P Sinha, Respiratory Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK; iansinha{at}liv.ac.uk

Abstract

Asthma is the most common chronic condition of childhood. In this review, we discuss an overview of strategies to empower children and young people with asthma. The key aspects of empowerment are to enable shared decision making and self-management, and help children minimise the impact of asthma on their life. The evidence behind these strategies is either sparse or heterogenous, and it is difficult to identify which interventions are most likely to improve clinical outcomes. Wider determinants of health, in high-resource and low-resource settings, can be disempowering for children with asthma. New approaches to technology could help empower young people with asthma and other chronic health conditions.

  • adolescent health
  • epidemiology
  • general paediatrics
  • health service
  • respiratory

https://doi.org/10.1136/archdischild-2020-318788

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @just_TUX

    • Contributors IPS is the guarantor and drafted the manuscript. All authors were involved in conceiving of the need for this review article. All authors reviewed dates of final manuscript and contributed to the intellectual property contained within it.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests CG has received fees from Flynn Pharma and Thermo Fisher Scientific for delivering lectures. AL has received fees from AbbVie Pharmaceuticals for delivering lectures. None of these is directly relevant to this paper.

    • Patient consent for publication Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data availability statement Data sharing not applicable as no datasets generated and/or analysed for this study. This is a review article with no primary data.